U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
(Check One):
[ ] Form 10-K or Form 10-KSB [ ] Form 20-F [ ] Form 11-K
[X] Form 10-Q or Form 10-QSB [ ] Form N-SAR
For Period Ended: March 31, 1997
[ ] Transition Report on Form 10-K or Form-KSB
[ ] Transition Report on Form 20-F
[ ] Transition Report of Form 11-K
[ ] Transition Report on Form 10-Q or Form 10-QSB
[ ] Transition Report on Form N-SAR
For the Transition Period Ended: ___________________
Read attached Instruction sheet before preparing form. Please print or
type.
Nothing in this form shall be construed to imply that the Commission
has verified any information contained herein.
- --------------------------------------------------------------------------------
If the notification relates to a portion of the filing checked above,
identify the Item(s) to which the notification relates:
PART 1 - Registrant Information
Full name of Registrant: SOURCE SCIENTIFIC, INC.
Former Name if applicable:
Address of Principal Executive
Office (Street and Number)
7390 Lincoln Way
City, State, and Zip Code
Garden Grove, California 92641
Part II - Rules 12b-25(b) and (c)
If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate)
[ ] (a) The reasons described in reasonable detail in Part III of this
form could not be eliminated without unreasonable effort or
expense;
[X] (b) The subject annual report, semi-annual report, transition
report on Form 10-K or Form 10-KSB, Form 20-F, 11-K or Form
N-SAR, or portion thereof will be filed on or before the fif-
teenth calendar day following the described due date; or the
subject quarterly report or transition report on Form 10-Q or
Form 10-QSB, or portion thereof will be filed on or before
the fifth calendar day following the prescribed due date; and
[ ] (c) The accountant's statement or other exhibit required by Rule
12b-25(c) has been attached if applicable.
Part III - Narrative
State below in reasonable detail the reasons why Form 10-K and Form 10-KSB,
20-F, 11-K, 10-Q and Form 10-QSB, N-SAR, or the transition report or portion
thereof could not be filed within the prescribed period.
In February 1997, a significant number of shares of common stock of the
Company were issued upon the conversion of an aggregate of $629,000 in
debentures. The financial information and Management's Discussion and Analysis
of Financial Condition and Results of Operation, as related to the financial
information and the conversion of debentures will not be completed in sufficient
time to file the Quarterly Report on Form 10-QSB for the period ended March 31,
1997, by May 15, 1997.
Part IV - Other Information
(1) Name and Telephone number of person to contact in regard to this
notification:
Randolf W. Katz (714) 252-7500
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under
Section 13 or 15(d) of the Securities Exchange
Act of 1934 or Section 30 of the Investment
Company Act of 1940 during the preceding [X] Yes [ ] No
12 months or for such shorter period
that the registrant was required to file such
report(s) been filed? If the answer is no,
identify report(s).
(3) Is it anticipated that any significant
change in results of operations from the
corresponding period for the last fiscal [ ] Yes [X ] No
year will be reflected by the earnings
statements to be included in the subject
report or portion thereof?
If so: attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate, state the
reasons why a reasonable estimate of the results cannot be made.
SOURCE SCIENTIFIC, INC.
(Name of Registrant as specified in charter)
has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Date: March 15, 1997 By: /s/CATHERINE CURTIS
------------------ -------------------
Catherine Curtis
Secretary
INSTRUCTION: The form may be signed by an executive officer of the
registrant or by any other duly authorized representative. The name and title of
the person signing the form shall be typed or printed beneath the signature. If
the statement is signed on behalf of the registrant by an authorized
representative (other than an executive officer), evidence of the
representative's authority to sign on behalf of the registrant shall be filed
with the form.
